A common genetic alteration in prostate cancer is a signature gene fusion between the androgen-regulated TMPRSS2 and the transformation-specific (ETS) transcription factor family members [13], [14], [15], [16]. The gene discussed is TMPRSS2; the disease is prostate carcinoma.